BioSpace News Archive

A global leader in healthcare technology, CompuGroup Medical (CGM) is expanding its US presence with the acquisition of Schuyler House, an established developer of laboratory information systems with headquarters in Valencia, California, and offices in Columbia, Missouri.

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, announced that it intends to offer and sell shares of its common stock in an underwritten public offering.

NanoVibronix, Inc., (NASDAQ: NAOV), a medical device company that produces the UroShield®, PainShield® and WoundShield® Surface Acoustic Wave (SAW) Portable Ultrasonic Therapeutic Devices, today announced the closing of its previously announced private placement of 8,571,429 shares of common stock

Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), will host its 2020 Analyst and Investor Event tomorrow, Tuesday, Dec. 8 from 9:00 a.m. to approximately 11:30 a.m. ET.

Innovent Biologics, Inc. (“Innovent”) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major diseases, today announced data from two ongoing Phase 2 studies evaluating parsaclisib,

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biotechnology company focused on developing and commercializing innovative medicines worldwide, today announced that the China National Medical Products Administration (NMPA) has approved BLINCYTO® (blinatumomab) for injection for the treatment of adult patients with relapsed or refractory (R/R) B-cell precursor acute lymphoblastic leukemia (ALL

Often perceived as a complicated tax code, Section 179 deductions are more straight forward than most businesses realize.

Arcturus Therapeutics Holdings Inc., a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases, announced the pricing of an underwritten public offering of 1,365,000 shares of its common stock at a public offering price of $110.00 per share.

Dec. 7, 2020 17:00 UTC How Geospatial Technology Can Be Applied to a Variety of Rigorous Methodologies REDLANDS, Calif.--( BUSINESS WIRE )-- Esri , the global leader in location intelligence, today announced the publication of GIS for Science: Applying Mapping and Spatial Analytics, Volume 2 . Most scientific study involves some spatial component, which is why professional scientists are increasingly applying geographic information system (GIS) technology to r

Dr. Isaacs, co-CEO of The Permanente Federation, Recognized for Demonstrating Leadership and Impact in Influencing the Health Care Industry